Bellerophon Therapeutics, Inc.
BLPH · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$19,831 | -$17,756 | -$24,728 | -$13,267 |
| Dep. & Amort. | $65 | $102 | $147 | $348 |
| Deferred Tax | $0 | $0 | $327 | $0 |
| Stock-Based Comp. | $786 | $1,126 | $1,633 | $2,152 |
| Change in WC | $1,211 | -$5,693 | $2,437 | -$161 |
| Other Non-Cash | -$1 | -$600 | $300 | -$2,008 |
| Operating Cash Flow | -$17,770 | -$22,821 | -$19,884 | -$12,936 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $54,696 | $6,236 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$40 | $0 | $2,871 | -$69 |
| Financing Cash Flow | -$40 | $0 | $57,567 | $6,167 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$17,810 | -$22,821 | $37,683 | -$6,769 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $25,139 | $47,960 | $10,277 | $17,046 |
| End Cash | $7,329 | $25,139 | $47,960 | $10,277 |
| Free Cash Flow | -$17,770 | -$22,821 | -$19,884 | -$12,936 |